Taysha Gene Therapies Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning, everybody. My name is Gil Blum, and I'm a senior biotech analyst here at Needham & Company covering the immuno-oncology and gene therapy sectors. It is my pleasure to have with me today Taysha's management team, including CEO, RA Session; Suyash Prasad, Chief Medical Officer; and Kamran Alam, Chief Financial Officer. (Conference Instructions)
Questions & Answers
So with that, RA, could you please provide an introduction for Taysha, the company's origin and kind of the primary focus?
Sure, sure. No, absolutely. And Gil, thank you, and thanks to Needham for having us today. So I'm RA Session, I'm Founder/CEO of Taysha Gene Therapies. Taysha Gene Therapies is a spinout of UT Southwestern based here in Dallas, Texas, particularly, the gene therapy group there, which is led by Dr. Steven Gray and Berge Minassian. Steve has a long story and history of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |